230
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Characterization of vitamin–cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue

, , , &
Pages 578-588 | Received 03 Dec 2014, Accepted 04 Jun 2015, Published online: 28 Jul 2015
 

Abstract

Context: Vitamins have been shown to reduce chemotherapy-related fatigue (CRF) by conserving energy loss both during and after cancer treatment. However, it remains unknown whether this reduction of fatigue interferes with the cancer drugs or alters the effectiveness of these agents. Objectives: The objective was to synthesize vitamin–cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue. Materials and methods: Multi-vitamin (C, D3, and B12)–cisplatin composite nano-formulation called NanoCisVital (NCV) to overcome CRF. The interactions between vitamins and NCV were characterized using scanning electron microscopy (SEM), Fourier transform infrared (FT-IR) spectroscopy, and a particle size analyser. The chemo-preventive activity was performed by in vitro bio assays. Results: SEM analysis showed spherical shape and the size is < 225 nm. NCV inhibited the proliferating yeast cells as well as denaturation of bovine serum albumin, and it also reduced the sprouting of new blood vessels in dose-dependent manner. Conclusion: Collectively, these results demonstrate that the NCV particles can be used to reduce CRF without much affecting the anti-cancer properties of cisplatin.

Acknowledgements

We thank Sathyabhama University, Chennai, and the Central Leather Research Institute (CLRI) in Chennai for conducting the characterization studies. We also thank the Department of Biotechnology (DBT) at New Delhi and K L E F University management for giving support for the study.

Declaration of interest

The authors disclose no conflict of interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.